By Natasha Roberts
Date: Thursday 17 May 2012
Things appear to be proceeding to plan at Hikma Pharmaceuticals as it has reiterated its revenue growth guidance for 2012, despite a few setbacks in its generic drugs business.
| London close: Stocks snap four-day winning streak | 30-Apr-2012 | ShareCast |
| FTSE 250 movers: Essar rebounds while Aquarius p... | 30-Apr-2012 | ShareCast |
| Monday broker round-up | 30-Apr-2012 | ShareCast |
| Broker tips: Burberry, M and S, Hikma | 17-Apr-2012 | ShareCast |
| Broker snap: UBS upgrades Hikma after recent falls | 17-Apr-2012 | ShareCast |
| Director/PDMR Shareholding | 18-May-2012 | 10:46 | RNS |
| Result of AGM | 17-May-2012 | 15:27 | RNS |
| Interim Management Statement | 17-May-2012 | 07:00 | RNS |
| Holding(s) in Company | 01-May-2012 | 15:50 | RNS |
| Holding(s) in Company | 20-Apr-2012 | 12:50 | RNS |
| Hikma prepares return to Libya | 26-Aug-2011 | The Independent |
| Hikma deals pay off | 19-Mar-2008 | Telegraph |
| Hikma launches bid for generic drugs firm | 08-Oct-2007 | Telegraph |
| Hikma bids £80m for Jordanian drug maker | 08-Oct-2007 | The Independent |
| Propriety alive and well on The Mound | 28-Jun-2007 | The Scotsman |
| Investment Column:Hikma | 02-Feb-2011 | The Independent |
| Questor:Hikma Pharmaceuticals | 23-Jul-2008 | Telegraph |
| Market Report: Respite for Rentokil after buyout... | 18-Jan-2008 | The Independent |
| Property sector buoyed by Laxey's £1bn opportuni... | 15-Jan-2008 | Telegraph |
| Avis Europe hits the buffers after downgrade | 06-Sep-2007 | The Independent |
No recent information was found.
| FTSE preview: Shares to follow US lower | 12-May-2011 | This Is Money |
| FTSE preview: Shares stable after Japan falls | 16-Mar-2011 | This Is Money |
| FTSE in-depth: More hiccups on way for Hikma | 02-Feb-2011 | This Is Money |
| Newspaper and magazine share tips | 01-Feb-2011 | This Is Money |
| FTSE in-depth: Dealers tuck into food retailers | 13-Nov-2010 | This Is Money |
| Currency | UK Pounds |
| Share Price | 629.50p |
| Change Today | 6.00p |
| % Change | 0.96 % |
| 52 Week High | 869.00p |
| 52 Week Low | 555.50p |
| Volume | 228,954 |
| Shares Issued | 196.81m |
| Market Cap | £1,238.90m |
| Beta | 0.82 |
| RiskGrade | 130 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 7 |
| Buy | 0 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 18-Apr-12 | 07-Sep-11 |
| Paid | 24-May-12 | 13-Oct-11 |
| Amount | 7.50¢ | 5.50¢ |
| Time | Volume / Share Price |
| 16:46 | 9,161 @ 628.65p |
| 16:45 | 2,977 @ 629.56p |
| 16:35 | 57,164 @ 629.50p |
| 16:29 | 200 @ 631.00p |
| 16:29 | 343 @ 629.50p |
| CEO | Said Darwazah |
| CFO | Khalid Nabilsi |
You are here: research